Prostate Cancer - Results from #1880

Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants. November 10, 2023

The Efficacy and Safety of Metastasis-directed Therapy in Patients with Prostate Cancer: A Systematic Review and Meta-analysis of Prospective Studies. November 10, 2023

The Novel Green Learning Artificial Intelligence for Prostate Cancer Imaging: A Balanced Alternative to Deep Learning and Radiomics. November 10, 2023

Determinants of Bone-Modifying Agent Prescribing for Metastatic Castration-Resistant Prostate Cancer in a National Health Care Delivery System November 9, 2023

Effect of BMI and hemoglobin A1c on survival of veterans with metastatic castration-resistant prostate cancer treated with abiraterone or enzalutamide. November 9, 2023

AI-powered radiomics: revolutionizing detection of urologic malignancies. November 9, 2023

Case Report: Targeting of individual somatic tumor mutations by multipeptide vaccination tailored for HLA class I and II presentation induces strong CD4 and CD8 T-cell responses in a patient with metastatic castration sensitive prostate cancer. November 9, 2023

Burden of prostate cancer in the Middle East: A comparative analysis based on global cancer observatory data. November 9, 2023

Patient Benefits of Radical Prostatectomy in Certified Prostate Cancer Centers: Comparative Results from the Multicenter IMPROVE Study. November 9, 2023

AdvanCell Announces First Patient Dosed in Phase I/II TheraPb Clinical Trial of 212Pb-ADVC001 in Metastatic Prostate Cancer November 8, 2023

De Novo Metastatic Prostate Cancer: Are We Moving toward a Personalized Treatment? November 8, 2023

Relationship between Eccentricity and Volume Determined by Spectral Algorithms Applied to Spatially Registered Bi-Parametric MRI and Prostate Tumor Aggressiveness: A Pilot Study. November 8, 2023

Association of Frailty and Complications Following Prostate Biopsy: Results from a Population-Based, Privately Insured Cohort. November 8, 2023

Antihormonal-Treatment Status Affects 68Ga-PSMA-HBED-CC PET Biodistribution in Patients with Prostate Cancer. November 8, 2023

AMG 509 (Xaluritamig), an Anti-STEAP1 XmAb 2+1 T-cell Redirecting Immune Therapy with Avidity-Dependent Activity Against Prostate Cancer. November 8, 2023

Transposable Elements Are Co-opted as Oncogenic Regulatory Elements by Lineage-Specific Transcription Factors in Prostate Cancer. November 8, 2023

Prostate Cancer in Transgender Women: Epidemiology, Clinical Characteristics, and Management Challenges. November 8, 2023

Development and Validation of a Tool to Identify Patients Diagnosed With Castration-Resistant Prostate Cancer. November 8, 2023

Comparison of salvage radical prostatectomy vs. salvage ablation therapy for biopsyproven radio-recurrent localized prostate cancer. November 8, 2023

Can MRI Help Inform Which Men with a History of Multifocal High Grade Prostatic Intraepithelial Neoplasia or Atypical Small Acinar Proliferation Remain at an Elevated Risk for Clinically Significant Prostate Cancer? November 8, 2023

Page 95 of 1439